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 Introduction 
 
Heart failure is a significant public health concern 
worldwide. Heart failure affects an estimated 1 percent of adults 50 to 60 
years of age and 10 percent of adults in their 80s. This clinical syndrome 
is the most frequent cause of hospitalization in patients older than 65 
years. Half of all patients with a diagnosis of heart failure will die within 
4 years, and in patients with severe heart failure, more than half will die 
in one year. 1, 2 
The prevalence of heart failure is higher in our country than 
in developed countries. This is because coronary artery disease in Indians 
occurs at a younger age, is more severe and extensive and follows a 
malignant course. 3. By the year 2020, the burden of cardiovascular 
disease in India will surpass that in other regions of the world4. The 
higher prevalence is directly related to the higher incidence and 
prevalence of hypertension and diabetes. This problem is particularly 
exacerbated by a lack of access to health care and to substandard 
preventive health care in India.  
While modern methods of diagnosing heart failure such as 
the echocardiogram, perfusion scan, Radionuclide angiography, Left 
ventricular angiography, Magnetic resonance imaging (MRI) and ultra 
fast or cine computed tomography etc are available in big cities, the 
 majority of our population must be content with the treatment and 
investigations available in the primary health center. Often the only 
investigations available here to evaluate a patient with suspected cardiac 
disorder are an electrocardiogram and a chest x ray. Therefore the treating 
physician has to make a decision regarding the presence of left 
ventricular dysfunction based on his clinical assessment and with the help 
of electrocardiogram and Chest X-ray. Diagnosis of heart failure is 
definitely possible with the help of a thorough clinical examination and 
simple tools such as electrocardiogram and chest X-Ray.  
Numerous studies have shown that left ventricular systolic 
dysfunction is very unlikely in a patient with a normal electrocardiogram. 
This means that left ventricular systolic dysfunction screening could be 
concentrated towards patients with abnormal electrocardiograms. Hence, 
especially in a developing country like ours it would be a cost effective 
approach to use the electrocardiogram as the initial investigation. In a 
study done by AP Davie et al if screening is restricted to those with major 
ECG abnormalities, the incidence of left ventricular systolic dysfunction 
increased from 18% to 37%.5.  If the tracing is normal other diagnoses 
should be considered. Only if these have been excluded should an 
echocardiogram be performed.  
Patients with congestive heart failure have a poor prognosis 
and many studies have shown mortalities of around 15% in the first year 
 and 30% in the second year. Even among patients with ischemic heart 
disease, the single most important prognostic factor is the degree of LV 
dysfunction. Although significant progress has been made in the 
treatment of heart failure, patients continue to have a poor quality of life 
and an unacceptably high mortality. 
The question often arises in our mind – if most patients with 
significant LV dysfunction have electrocardiographic abnormalities then, 
are there any specific electrocardiographic abnormalities specific for 
diagnosing systolic heart failure?  
 Aims of the Study 
 
1. To study specific ECG changes in patients with and left ventricular 
systolic dysfunction. 
2. To determine if there is an association between decreasing Ejection 
fraction and the electrocardiogram. 
3. To quantify the association between certain electrocardiographic 
criteria and left ventricular systolic dysfunction. 
 Review of the literature. 
Heart failure is primarily a disease of the elderly.6 It is 
responsible for 5 to 10 percent of all hospital admissions. Approximately 
6% to 10% of people older than 65 years have heart failure.7 Around 80% 
of patients hospitalized with heart failure are more than 65 years old.8 
Heart failure causes or contributes to approximately 250,000 deaths every 
year. Although significant progress has been made in the treatment of 
heart failure, patients continue to have a poor quality of life and an 
unacceptably high mortality. 
Definition 
By definition Heart failure is the pathophysiologic state in 
which the heart, via an abnormality of cardiac function (detectable or 
not), fails to pump blood at a rate commensurate with the requirements of 
the metabolizing tissues and/or pumps only from an abnormally elevated 
diastolic filling pressure.9 
Pathophysiology  
Heart failure may be caused by myocardial failure but may 
also occur in the presence of near-normal cardiac function under 
conditions of high demand. Heart failure always causes circulatory 
failure, but the converse is not necessarily the case because various 
noncardiac conditions (e.g., hypovolemic shock, septic shock) can 
 produce circulatory failure in the presence of normal, modestly impaired, 
or even supranormal cardiac function. 
Inadequate adaptation of the cardiac myocytes to increased 
wall stress in order to maintain adequate cardiac output following 
myocardial injury (whether of acute onset or over several months to 
years, whether a primary disturbance in myocardial contractility or an 
excessive hemodynamic burden placed on the ventricle, or both), is the 
inciting event in CHF. 
Most important among these adaptations are the (1) Frank-
Starling mechanism, in which an increased preload helps to sustain 
cardiac performance; (2) myocardial hypertrophy with or without cardiac 
chamber dilatation, in which the mass of contractile tissue is augmented; 
and (3) activation of neurohumoral systems, especially the release of 
norepinephrine (NE) by adrenergic cardiac nerves, which augments 
myocardial contractility and the activation of the renin-angiotensin-
aldosterone system (RAAS) and other neurohumoral adjustments that act 
to maintain arterial pressure and perfusion of vital organs. 
The primary myocardial response to chronic increased wall 
stress includes myocyte hypertrophy and remodeling, usually of the 
eccentric type. The reduction of cardiac output following myocardial 
injury sets into motion a cascade of hemodynamic and neurohormonal 
derangements that provoke activation of neuroendocrine systems, most 
 notably the above-mentioned adrenergic systems and renin-angiotensin-
aldosterone system. The release of epinephrine (E) and NE, along with 
the vasoactive substances endothelin-1 (ET-1) and vasopressin (V), 
causes vasoconstriction, which increases afterload, and, via an increase in 
cyclic adenosine monophosphate (cAMP), causes an increase in cytosolic 
calcium entry. The increased calcium entry into the myocytes augments 
myocardial contractility and impairs myocardial relaxation (lusitropy).  
The calcium overload may also induce arrhythmias and lead 
to sudden death. The increase in afterload and myocardial contractility 
(known as inotropy) and the impairment in myocardial lusitropy lead to 
an increase in myocardial energy expenditure and a further decrease in 
cardiac output. The increase in myocardial energy expenditure leads to 
myocardial cell death, resulting in heart failure and further reduction in 
cardiac output, thus starting an accelerating cycle of further increased 
neurohumoral stimulation and further adverse hemodynamic and 
myocardial responses as described above. 
 The activation of the renin-angiotensin-aldosterone system 
leads to salt and water retention, resulting in increased preload and further 
increases in myocardial energy expenditure. Increases in renin, mediated 
by decreased stretch of the glomerular afferent arteriole, reduced delivery 
of chloride to the macula densa, and increased beta1-adrenergic activity 
as a response to decreased cardiac output, results in an increase in 
 angiotensin II levels and, in turn, aldosterone levels. This results in 
stimulation of release of aldosterone. Angiotensin II, along with ET-1, is 
crucial in maintaining effective intravascular homeostasis mediated by 
vasoconstriction and aldosterone-induced salt and water retention. 
 As heart failure advances and/or becomes progressively 
decompensated, there is a relative decline in the counter regulatory 
effects of endogenous vasodilators, including nitric oxide (NO), 
prostaglandins (PGs), bradykinin (BK), atrial natriuretic peptide (ANP), 
and B-type natriuretic peptide (BNP). This occurs simultaneously with 
the increase in vasoconstrictor substances from the renin-angiotensin-
aldosterone system and adrenergic systems. This fosters further increases 
in vasoconstriction and thus preload and afterload, leading to cellular 
proliferation, adverse myocardial remodeling, and antinatriuresis with 
total body fluid excess and worsening CHF symptoms. 
 
 
Natriuretic peptides 
ANP and BNP are endogenously generated peptides 
activated in response to atrial and ventricular volume/pressure expansion. 
ANP and BNP are released from the atria and ventricles, respectively, 
and both promote vasodilation and natriuresis. Their hemodynamic 
effects are mediated by decreases in ventricular filling pressures, owing 
 to reductions in cardiac preload and afterload. BNP, in particular, 
produces selective afferent arteriolar vasodilation and inhibits sodium 
reabsorption in the proximal convoluted tubule. BNP inhibits renin and 
aldosterone release and, possibly, adrenergic activation as well. 
 Both ANP and BNP are elevated in chronic heart failure. 
BNP, in particular, has potentially important diagnostic, therapeutic, and 
prognostic implications. A large study has confirmed that BNP could help 
differentiate cardiac from respiratory acute breathlessness in the 
emergency room setting.10 In particular; the negative predictive accuracy 
was 97%. The positive predictive value was also high at 70%.11,12 
Systolic and diastolic heart failure 
There are two types of heart failure – systolic and diastolic.  
In systolic heart failure, there is reduced cardiac contractility (decreased 
left ventricular systolic function with an ejection fraction less than 50%), 
whereas in diastolic heart failure there is impaired cardiac relaxation and 
abnormal ventricular filling (symptoms and signs of heart failure in the 
presence of normal ejection fraction). Both systolic and diastolic heart 
failure result in a decrease in stroke volume. This leads to activation of 
peripheral and central baroreflexes and chemoreflexes that are capable of 
eliciting marked increases in sympathetic nerve traffic.  
In individuals with systolic dysfunction, the neurohormonal 
responses to decreased stroke volume result in temporary improvement in 
 systolic blood pressure and tissue perfusion. However, in all 
circumstances, the existing data support the notion that these 
neurohormonal responses accelerate the downward spiral of myocardial 
dysfunction in the long term. 
In diastolic heart failure, the same pathophysiologic 
processes to decreased cardiac output that occur in systolic heart failure 
also occur, but they do so in response to a different set of hemodynamic 
and circulatory environmental factors that depress cardiac output.  
Etiology of heart failure 
There are several causes for heart failure. However in about 
two thirds the cause of heart failure is coronary artery disease.13 The 
etiology differs in doth systolic and diastolic heart failure but a significant 
overlap occurs. The principal causes are mentioned below.  
Dominant systolic heart failure  
1. Ischemic myocardial disease, coronary artery disease 
2. Alcoholic cardiomyopathy 
3. Diabetic cardiomyopathy  
4. Cocaine cardiomyopathy  
5. Drug-induced cardiomyopathy (e.g., doxorubicin)  
6. Idiopathic cardiomyopathy  
7. Peripartum cardiomyopathy  
8. Myocarditis  
 9. Preterminal valvular heart disease  
10. Congenital heart disease with severe pulmonary hypertension  
Dominant diastolic heart failure  
1. Hypertension  
2. Severe aortic stenosis  
3. Hypertrophic cardiomyopathy  
4. Restrictive cardiomyopathy  
5. Ischemic myocardial disease, coronary artery disease 
6. Acute heart failure 
7. Acute mitral or aortic regurgitation 
8. Rupture of valve leaflets or supporting structures  
9. Infective endocarditis with acute valve incompetence 
10. Myocardial infarction 
11. High-output heart failure  
12. Anemia  
13. Systemic arteriovenous fistulas  
14. Hyperthyroidism  
15. Beriberi heart disease  
16. Paget disease of bone  
 
Precipitating factors  
 In a study conducted by Chin MH et al out of 435 
patients admitted with heart failure, precipitating factors could be 
identified in 66%.14 A well compensated patient with heart failure may 
become decompensated due to numerous precipitating factors and not 
necessarily due to worsening heart failure. The most common of these 
are inappropriate reduction in the intensity of treatment, be it dietary 
sodium and fluid restriction or pharmacological therapy. Other 
important precipitating factors include arrhythmias, systemic 
infection, physical, emotional and environmental stress, pulmonary 
disease and development of an unrelated illness.  
 
Stages  
The evolution of heart failure from an asymptomatic to a 
symptomatic stage has recently been classified.15 
ACC/AHA Classification of Chronic Heart Failure  
Stage Description  
A.  High risk for developing heart failure. (Hypertension, 
diabetes  mellitus, CAD, family history of cardiomyopathy ) 
B.  Asymptomatic heart failure. (Previous MI, LV dysfunction, 
 valvular heart disease ) 
C.  Symptomatic heart failure. (Structural heart disease, dyspnea 
 and fatigue, impaired exercise tolerance)  
 D.  Refractory end-stage heart failure. (Marked symptoms at rest 
 despite maximal medical therapy) 
The clinical syndrome of heart failure manifests when 
cellular respiration becomes impaired. The Framingham, Duke and 
Boston criteria were established before noninvasive techniques for 
assessing systolic and diastolic dysfunction became widely available. The 
three sets of criteria were designed to assist in the diagnosis of heart 
failure. The Boston criteria16   have been shown to have the highest 
combined sensitivity (50 percent) and specificity (78 percent). All of 
these criteria are most helpful in diagnosing advanced or severe heart 
failure, a condition that occurs in 20 to 40 percent of patients with a 
decreased ejection fraction.  
Boston Criteria for Diagnosing Heart Failure 
Category I: history  Points  
Rest dyspnea  4 
Orthopnea  4 
Paroxysmal nocturnal dyspnea  3 
Dyspnea while walking on level area  2 
Dyspnea while climbing  1 
Category II: physical examination   
Heart rate abnormality (1 point if 91 to 110 beats per 
minute; 2 points if more than 110 beats per minute)  
1 or 2 
Jugular venous elevation (2 points if greater than 6 cm 
H2O; 3 points if greater than 6 cm H2O plus 
2 or 3 
 hepatomegaly or edema)   
Lung crackles (1 point if basilar; 2 points if more than 
basilar)  
1 or 2 
Wheezing  3 
Third heart sound  3 
Category III: chest radiography   
Alveolar pulmonary edema  4 
Interstitial pulmonary edema  3 
Bilateral pleural effusion  3 
Cardiothoracic ratio greater than 0.50  3 
Upper zone flow redistribution  2 
 
No more than 4 points are allowed from each of three 
categories; hence the composite score (the sum of the subtotal from each 
category) has a possible maximum of 12 points. The diagnosis of heart 
failure is classified as "definite" at a score of 8 to 12 points, "possible" at 
a score of 5 to 7 points, and "unlikely" at a score of 4 points or less.  
Early diagnosis of heart failure is essential for successfully 
addressing underlying diseases or causes and, in some patients, 
preventing further myocardial dysfunction and clinical deterioration. 
However, initial diagnosis may be difficult because the presentations of 
heart failure can change from no symptoms to pulmonary edema with 
cardiogenic shock. It is estimated that heart failure is correctly diagnosed 
initially in only 50 percent of affected patients.17 
 The first step in diagnosing heart failure is to obtain a 
complete clinical history. The patient should be questioned about 
dyspnea, cough, nocturia, generalized fatigue and other signs and 
symptoms of heart failure. Peripheral edema, raised jugular venous 
pressure and hepatomegaly are the characteristic feature of congestion of 
systemic veins.18,19 
Dyspnea, a cardinal symptom of a failing heart, often 
progresses from dyspnea on exertion to orthopnea, paroxysmal nocturnal 
dyspnea and dyspnea on rest. Cough, usually nocturnal and 
nonproductive, may accompany dyspnea and often occurs in similar 
settings (i.e., on exertion or when the patient is supine). 
The NYHA functional classification scheme is used to assess 
the severity of heart failure and correlates fairly well with prognosis.20 
New York Heart Association Heart Failure Symptom Classification 
System   
 
I   No symptom limitation with ordinary physical activity  
II   Ordinary physical activity somewhat limited by dyspnea (i.e., long 
 distance walking, climbing 2 flights of stairs)  
III   Exercise limited by dyspnea at mild work loads (ie, short distance 
 walking, climbing one flight of stairs)  
IV   Dyspnea at rest or with very little exertion  
     
Nocturia, also a frequent sign of heart failure, occurs 
secondary to increased renal perfusion when the patient is supine.203 
Generalized fatigue (caused by the low perfusion state) and peripheral 
edema with inability to wear usual footwear are frequent complaints. 
 With severe, longstanding heart failure, cardiac cachexia 
(emaciation resulting from heart disease) may develop secondary to 
protein-losing enteropathy and increased levels of certain cytokines, such 
as tumor necrosis factor. Cardiac cachexia may mimic the cachexia seen 
in patients with disseminated malignant disease. 
Confusion and altered mental status may occur because of 
decreased cerebral perfusion or cardiac cirrhosis. In heart failure, 
cirrhosis develops secondary to chronic passive congestion of the liver. 
The patient should be asked about previous chest pain or 
myocardial infarction because coronary artery disease is responsible for 
up to 75 percent of cases of heart failure with decreased left ventricular 
function.5 A history of myocardial infarction has a better combination of 
sensitivity, specificity and positive and negative predictive value for heart 
failure compared with other symptoms or aspects of the medical history.5 
Once heart failure is suspected, the functional class of the 
patient should be determined. The New York Heart Association (NYHA) 
 functional classification of congestive heart failure is commonly used in 
clinical practice.  
 
 
Physical Examination  
A complete physical examination is the second component 
in the diagnosis of heart failure. The patient’s general appearance should 
be assessed for evidence of resting dyspnea, cyanosis and cachexia. 
Blood Pressure and Heart Rate 
The patient’s blood pressure and heart rate should be 
recorded. High, normal or low blood pressure may be present. The 
prognosis is worse for patients who present with a systolic blood pressure 
of less than 90 to 100 mm Hg when not receiving medication 
(angiotensin-converting enzyme [ACE] inhibitors, beta blockers or 
diuretics). Tachycardia may be a sign of heart failure, especially in the 
decompensated state. The heart rate increases as one of the compensatory 
ways of maintaining adequate cardiac output. A decrease in the resting 
heart rate with medical therapy can be used as a surrogate marker for 
treatment efficacy. A weak, thready pulse and pulsus alternans are 
associated with decreased left ventricular function. The patient should 
also be monitored for evidence of periodic breathing (Cheyne-Stokes 
respiration). 
 Jugular Venous Distention 
Jugular venous distention is assessed while the patient is 
supine with the upper body at a 45-degree angle from the horizontal 
plane. The top of the waveform of the internal jugular venous pulsation 
determines the height of the venous distention. A height of more than 4 to 
5 cm from the sternal angle is considered significant. 
Elevated jugular venous pressure is a specific (90 percent) 
but not sensitive (30 percent) sign of elevated left ventricular filling. The 
reproducibility of the jugular venous distention assessment is low.23 
Point of Maximal Impulse 
The point of maximal impulse of the left ventricle is usually 
located in the midclavicular line at the fifth intercostal space. 
Cardiomegaly usually displaces the cardiac impulse laterally and 
downward. 
Third and Fourth Heart Sounds 
A double apical impulse can represent an auscultated third 
heart sound (S3). Just as with the displaced point of maximal impulse, a 
third heart sound is not sensitive (24 percent) for heart failure, but it is 
highly specific (99 percent).5 
 Patients with heart failure and left ventricular hypertrophy 
can also have a fourth heart sound (S4). The physician should be alert for 
 murmurs, which can provide information about the cause of heart disease 
and also aid in the selection of therapy. 
 
Pulmonary Examination 
Physical examination of the lungs may reveal crepitations 
and pleural effusions. Despite the presence of pulmonary congestion, 
crepitations can be absent because of increased lymphatic drainage and 
compensatory changes in the perivascular structures that have occurred 
over time. Wheezing may be the sole manifestation of pulmonary 
congestion. Frequently, asthma is erroneously diagnosed in patients who 
actually have heart failure. 
Liver Size and Hepatojugular Reflux 
The key component of the abdominal examination is the 
evaluation of liver size. Hepatomegaly may occur because of right-sided 
heart failure and venous congestion. 
The hepatojugular reflux can be a useful test in patients with 
right-sided heart failure. This test should be performed while the patient 
is lying down with the upper body at a 45-degree angle from the 
horizontal plane. The patient keeps the mouth open and breathes normally 
to prevent Valsalva’s maneuver, which can give a false-positive test. 
Moderate pressure is then applied over the middle of the abdomen for 30 
to 60 seconds. Hepatojugular reflux occurs if the height of the neck veins 
 increases by at least 3 cm and the increase is maintained throughout the 
compression.23  
Lower Extremity Edema 
Lower extremity edema, a common sign of heart failure, is 
usually detected when the extracellular volume exceeds 5 L. The edema 
may be accompanied by stasis dermatitis, an often chronic, usually 
eczematous condition characterized by edema, hyperpigmentation and, 
commonly, ulceration. 
Valsalva’s Maneuver 
Valsalva’s maneuver is rarely used in the evaluation of 
patients with heart failure. Yet this test is simple to perform and carries 
one of the best combinations of specificity (91 percent) and sensitivity 
(69 percent) for the detection of left ventricular systolic and diastolic 
dysfunction in patients with heart failure. 25 
Valsalva’s maneuver is performed with the blood pressure 
cuff inflated 15 mm Hg over the systolic blood pressure. While the 
physician auscultates over the brachial artery, the patient is asked to 
perform a forced expiratory effort against a closed airway (the Valsalva’s 
maneuver). 
A normal response would be an initial rise in systolic blood 
pressure at the onset of straining (phase I) with Korotkoff’s sounds heard. 
While the maneuver is maintained (phase II), a decrease in the blood 
 pressure occurs with loss of Korotkoff’s sounds. Release of the maneuver 
(phase III) is followed by an overshoot of blood pressure and the 
reappearance of heart sounds (phase IV). Abnormal responses occurring 
in patients with heart failure are maintenance of beats throughout 
Valsalva’s maneuver (square wave) or lack of reappearance of 
Korotkoff’s sounds after release of the maneuver (absent overshoot).   
Laboratory Findings 
Most patients with heart failure have normal electrolyte 
levels. However, extended use of kaliuretic diuretics can lead to 
hypokalemia, and the use of potassium-sparing diuretics and ACE 
inhibitors may result in hyperkalemia. Blood urea nitrogen and creatinine 
levels may become elevated, reflecting prerenal azotemia. Hyponatremia 
may be present in patients with advanced heart failure. 
When the liver becomes congested, serum transaminase and 
bilirubin levels may become elevated, and jaundice may be present. With 
chronic congestive hepatomegaly, cardiac cirrhosis may occur and cause 
hypoalbuminemia, hypoglycemia and an increased prothrombin time. 
The prognosis is worse in patients with hyponatremia or 
abnormalities secondary to congested hepatomegaly. 
Anemia may contribute to worsening heart failure. When 
severe, anemia may even cause heart failure. 
 In all patients with newly diagnosed heart failure, thyroid 
function tests should be performed to rule out hypothyroidism or 
hyperthyroidism. 
It may soon be possible to routinely obtain serum 
measurements of two plasma enzymes secreted by the overloaded heart. 
Plasma atrial natriuretic peptide is secreted in response to increased intra-
atrial pressure, and brain natriuretic peptide (BNP) is secreted by the 
failing ventricle. Levels of these enzymes, but specifically BNP, are 
elevated in patients with dyspnea resulting from heart failure. In one 
study, elevated BNP levels had more than a 90 percent specificity and 
sensitivity for heart failure. 26 
Diagnostic Tests  
Patients with heart failure and atrial fibrillation, atrial 
tachycardia, ventricular tachycardia or left bundle branch block have a 
worse prognosis than patients with heart failure who do not have these 
electrocardiographic findings.    
Electrocardiography 
An electrocardiogram (ECG) should be obtained in all 
patients who present with heart failure.  A normal electrocardiogram 
suggests that the diagnosis of Heart failure should be carefully reviewed. 
The negative predictive value of normal electrocardiogram to exclude LV 
systolic dysfunction exceeds 90%.27 On the other hand, the presence of 
 anterior Q waves and a left bundle branch block in patients with ischemic 
heart disease are good predictors of decreased Ejection fraction.28 
Electrocardiographic signs of left atrial overload or left ventricular 
hypertrophy may be associated with systolic as well as isolated diastolic 
dysfunction, but they have a low predictive value. A QRS width of more 
than 120 milliseconds suggests that cardiac dyssynchrony may be present 
and a target for therapy. The electrocardiogram is crucial for detecting 
atrial fibrillation or flutter, and sometimes ventricular arrhythmia, all of 
which are causative or contributive factors for heart failure. The 
diagnostic contribution of the electrocardiogram increases if completed 
with clinical signs and symptom of cardiac failure. 
Chest Radiography 
Chest radiographs can be helpful in the diagnosis of heart 
failure. Cardiomegaly is usually manifested by the presence of an 
increased cardiothoracic ratio (greater than 0.50) on a posteroanterior 
view. However, patients with predominantly diastolic dysfunction may 
have normal heart size, one of the distinguishing markers of diastolic 
versus systolic dysfunction. Similarly Cardiomegaly is frequently absent 
in patients with acute heart failure of any cause. Right ventricular 
enlargement is suggested by the loss of free space between the cardiac 
silhouette and the sternum on a lateral view. 
 Signs of increased pulmonary venous pressure seen on chest 
radiographs may progress from redistribution of blood flow from the 
bases of the lungs to the apices to linear densities reflecting interstitial 
edema (Kerley’s lines) to a hazy appearance concentrated mostly around 
the hila of the mediastinum and presenting a butterfly pattern. 
Echocardiography 
Transthoracic two-dimensional echocardiography with 
Doppler flow studies is the investigation of choice for all patients with 
heart failure.29 This test helps in the assessment of left ventricular size, 
mass and ejection fraction. 
The ejection fraction is defined as the ratio of the stroke 
volume to end diastolic volume. It is most often computed as follows 
EF = EDV – ESV / EDV x 100 (%) 
The ejection fraction can be calculated by several methods, 
including visual estimation, which has good correlation with ejection 
fractions obtained by angiography30 or radionuclide cineangiography.31 
Regional wall motion and valvular integrity, can also be evaluated. 
Transesophageal echocardiography offers higher quality 
images than transthoracic studies. However, this technique is invasive 
and is best reserved for use when the quality of the two-dimensional 
echocardiogram is unacceptable. 
Angiography 
 Radionuclide angiography is another noninvasive method for 
assessing systolic and diastolic function. This imaging technique is used 
when two-dimensional echocardiography is not diagnostic because 
adequate images could not be obtained or the findings do not agree with 
the clinical picture. Radionuclide angiography provides a reliable and 
quantitative measurement of the left ventricular ejection fraction and the 
regional wall motion. Left ventricular angiography can be used to assess 
the ejection fraction, the left ventricular volume and the severity of 
valvular regurgitation or stenosis.  
Other Techniques 
Magnetic resonance imaging (MRI) and ultrafast or cine 
computed tomography (CT) 31 can measure the ejection fraction and 
assess regional wall motion. However, assessment of cardiac function 
using these studies is only performed in a limited number of centers, and 
the superiority of the studies to echocardiography and angiography has 
not been proved. 
 In patients with known coronary artery disease and heart 
failure but no angina, coronary arteriography or noninvasive testing (i.e., 
a thallium stress test or stress echocardiogram), followed by coronary 
arteriography in those patients with ischemia, should be considered. The 
intensity of the search for ischemic heart disease in patients with heart 
 disease depends on the patient’s probability of having coronary artery 
disease. 
 
The electrocardiogram 
An electrocardiogram or ECG (also known as EKG - 
abbreviated from the German word Elektro-Kardiographie), is surface 
measurement of the electrical potential generated by electrical activity in 
cardiac tissue. It is the product of a series of technological and 
physiological advances pioneered over the past two centuries.32 British 
physiologist Augustus D. Waller was the pioneer of electrocardiography 
and in 1887 published the first human electrocardiogram. Yet in 1911 
Waller said, “I do not imagine that electrocardiography is likely to find 
any very extensive use in the hospital. It can at most be of rare and 
occasional use to afford a record of some rare anomaly of cardiac action.” 
However, the invention of the string galvanometer in 1901 by Dutch 
physiologist, Willem Einthoven provided a reliable and direct method of 
registering electrical activity of the heart.  13 years later, the Nobel Prize 
in Medicine was awarded to Willem Einthoven. 
 
Basic principles 
The electrocardiogram is a graphic recording of the electric 
potentials generated by the heart. The signals are detected by means of 
 metal electrodes attached to the extremities and chest wall and are then 
amplified and recorded by the electrocardiograph. ECG leads actually 
display the instantaneous differences in potential between these 
electrodes. The clinical utility of the ECG derives from its immediate 
availability as an invasive, inexpensive and highly versatile test.  
In addition to its use in detecting arrhythmias, conduction 
disturbances and myocardial ischemia, electrocardiography may reveal 
other findings related to life threatening metabolic disturbances (eg. 
Hyperkalemia) or increased susceptibility to sudden cardiac death (e.g. 
QT prolongation syndromes)  
The standard clinical Electrocardiogram includes recording 
from 12 leads. These 12 leads includes 3 bipolar (leads I, II and III), 6 
unipolar precordial leads (leads V1 through V6) and 3 modified unipolar 
limb leads (the augmented leads aVR, aVL and aVF).  
Einthoven’s Law 
The electrical connections for these leads are such that the 
potential in lead II equals the sum of potentials sensed in leads I and III 
I + III = II  
This relationship is known as Einthoven’s Law or 
Einthoven’s equation. 
ECG waveforms and intervals 
 The standard 12 lead electrocardiogram is composed of 
waves complexes, intervals and segments. Waves are positive and 
negative deflection in the electrocardiograph baseline. The waves are 
labeled alphabetically beginning with the letter P. Interval refers to the 
length of a wave plus the isoelectric line that follows it. The length of an 
interval ends when another wave begins. They are named by using the 
letters of both waves on either side. Intervals contain waves. Segments 
refer to the baseline between the end of one wave and the beginning of 
the next wave. Segments are the lines between waves.  
These include in the normal sinus rhythm the P wave, PR 
Interval, PR Segment, QRS Complex, ST Segment, QT Interval, T wave 
and occasionally U wave.   
The P wave is caused by atrial depolarization. Electrical 
impulses originating in the SA node trigger atrial depolarization. The 
normal P wave is no more than 0.1 second in duration and 2.5mm high. 
The direction of electrical activity is from SA to AV node. The P wave is 
a representation of the time it takes for atrial depolarization. It is viewed 
normally as small and curved with a positive deflection. Seen at it's tallest 
on lead II. 
The PR interval is the portion of the electrocardiogram wave 
from the beginning of the P wave (onset of atrial depolarization) to the 
 beginning of the QRS complex (onset of ventricular depolarization). It is 
normally 0.12 - 0.20 seconds. 
The PR segment is the portion on the electrocardiogram 
wave from the end of the P wave to the beginning of the QRS complex. 
The PR segment corresponds to the time between the end of atrial 
depolarization to the onset of ventricular depolarization. It is an 
isoelectric segment. 
The QRS complex represents the time it takes for 
depolarization of the ventricles. - Due to ventricular depolarization. It 
consists of three waveforms. The normal complex begins with a 
downward deflection known as the Q wave, followed by an upward 
deflection called the R wave. The next downward deflection will be the S 
wave. All ventricular complexes are known as QRS complexes even if 
every wave is not present in all complexes. The normal QRS is 0.04 to 
0.12 seconds measured from the first deflection to the end of the QRS 
complex. 
QT Interval is the beginning of the QRS complex to the end 
of the T wave. In the presence of a U wave the measure should be from 
the beginning of the QRS complex to the end of the U wave. 
ST Segment is the length between the end of the S wave of 
the QRS complex and the beginning of the T wave. It is electrically 
neutral.  
 The ST Segment represents the period of ventricular muscle 
contraction before repolarization. The ST segment is normally isoelectric.  
The QT interval begins at the onset of the QRS complex and 
to the end of the T wave. It represents the time of ventricular 
depolarization until ventricular repolarization.  
The T wave is due to ventricular repolarization.  The polarity 
of the T wave is generally the same as the net polarity of the preceding 
QRS complex. T waves are usually upright in leads I, II, aVL, aVF and 
the lateral precordial leads.  
The U wave is a low amplitude wave that may follow the T 
wave. It is largest in mid precordial leads at slow heart rates. It is of the 
same deflection as T Wave and similar to shape to P Wave. The U Wave 
is thought to represent late repolarization of the Purkinje fibers in the 
Ventricles and is more often not shown on a rhythm strip. 
 
ECG in left ventricular systolic dysfunction 
Systolic dysfunction of the left ventricle not only results in 
an mechanical failure where in the left ventricle is not able to pump a 
stroke volume that is adequate tissues, but also leads to a disarray of the 
myocytes which lead to a change in their electric potential. This is 
reflected in the surface electrocardiogram. A dilated left ventrical which 
occurs in all cases of long standing systolic dysfunction produces an 
 electrocardiographic picture of chamber hypertrophy and more 
commonly an increase in QRS duration 
Numerous studies have shown that left ventricular systolic 
dysfunction is unlikely to be present if the electrocardiogram is normal 
(or shows only minor abnormalities). Conversely, there is usually a major 
electrocardiographic abnormality in the presence of increasing left 
ventricular systolic dysfunction.33 
Prolongation of QRS (120 ms) occurs in 14% to 47% of 
heart failure (HF) patients. Left bundle branch block is far more common 
than right bundle branch block.34 In a study done by A P Davie et al in 
1996, Western General Hospital, Edinburgh, a total of 534 patients aged 
17-94 were assessed. Ninety six had impaired left ventricular systolic 
function. Of these, 90 had major electrocardiographic abnormalities 
(atrial fibrillation, previous myocardial infarction, left ventricular 
hypertrophy, bundle branch block, or left axis deviation); none had a 
normal electrocardiogram. Of 438 patients with normal left ventricular 
systolic function, 169 had major electrocardiographic abnormalities.5 
In another study conducted by Xiao HB, Roy C, Fujimoto S, Gibson DG 
et al., 1996, 58 patients with dilated cardiomyopathy were followed for 4 
years. A QRS duration over 160 ms was found in 8 out of the 10 patients 
who died, 6 of 9 who had a pacemaker and only in 5 out of the 39 stable 
patients (P < 0.001).40 
 A prolonged QRS duration AND the presence of LBBB as a marker of 
significant left ventricular systolic dysfunction was confirmed by several 
studies.35,36  
Apart from wide QRS duration and bundle branch blocks, up 
to 50% of heart failure patients have minor intraventricular conduction 
delays that result in abnormal electrical depolarisation of the heart and 
mechanical asynchrony of the ventricles. Hence examination of a surface 
ECG would pick up these changes.    
Amplitude of the QRS complex also predicts left ventricular 
dysfunction. In a study done by Wilensky RL et al., 1998, progressive 
electrocardiographic changes were common in patients with idiopathic 
dilated cardiomyopathy and QRS amplitude criteria were accurate in the 
prediction of left ventricular dysfunction.37  
There are also data which suggest that in more advanced 
stages of congestive heart failure, power spectral analysis of heart rate 
variability allows identification of a subgroup of patients with higher 
sympathetic activation and poorer clinical status who are at major risk of 
adverse events.38, 39 
 Methods and materials used. 
 
Study population 
The study was conducted among 50 randomly selected 
patients referred to the Cardiology Department of Government 
Royapettah Hospital for cardiac evaluation. Another 50 patients who had 
normal left ventricular systolic function were used as controls.  
Study duration  
The period of study was from July 2004 to December 2005. 
Inclusion criteria 
1. Adult patients between ages 18 to 80 
2. Left ventricular systolic function as defined by 
an EF< 50 % in ECHO (the study population) 
Exclusion criteria  
1 Patients with myocarditis. 
2. Recent Myocardial infarction. 
3. Presence of pericardial effusion. 
4. Patients in Cardiogenic Shock. 
 
Study protocol 
 The patients included in the study were evaluated clinically. 
An experienced cardiologist performed transthoracic two-dimensional 
 echocardiography with Doppler flow. Left ventricular systolic function 
was quantified in terms of fractional shortening derived from M mode. 
Regional wall motion and valvular integrity were also evaluated. 
Normal ejection fraction was defined as an ejection fraction 
of 0.50 or more (50%). Left ventricular systolic dysfunction was defined 
as an ejection fraction less than 0.50 (50%), an arbitrary definition based 
on criteria used in studies such as the SOLVD study. 
The patients were classified into study population 
(EF<50%) and control population (EF > 50%). The study population was 
furthered categorized into those with mild, moderate and severe left 
ventricular systolic dysfunction. The classification used in our study is 
shown below. 
 
 Mild Moderate Severe 
Ejection fraction (%) 40- 49 30- 39 <30 
 
  
Both the control and study population were evaluated 
clinically.  A standard 12 lead electrocardiogram along with a rhythm 
strip was analyzed in detail and the study performa was completed.  
The following points were noted in the electrocardiogram – 
normal or abnormal, rate, rhythm, axis, presence of atrial or ventricular 
ectopics, conduction defects, left atrial Abnormality, ventricular 
enlargement and QRS duration.  
The presence of certain electrocardiographic criteria such as 
the Q waves, ST Segment and T wave abnormalities were not taken into 
account as majority of the patients had ischemic heart disease.  
For the purpose of the study the following criteria were 
observed when interpreting the electrocardiogram. 
Rate 
A rate of more than 100   –Tachycardia 
 A rate of less than 60   – Bradycardia 
Normal sinus rhythm 
 Equal R-R, PR, PP intervals  
 Each p wave followed by a QRS complex 
 P waves with normal morphology  
 P wave rate 60 - 100 bpm with <10% variation 
Axis 
   Normal Axis   – 30 to +100 degrees 
  Left Axis deviation  – 90 to – 30 degrees  
  Right Axis deviation  +100 to +180 degrees    
Left atrial abnormality  
  Broad, notched P waves in II and AVF (greater than 2.5 
 millimeters  wide)  
   A negative component in V1 or V2 (that exceeds one millimeter 
by  one millimeter, e.g., 40 milliseconds by 0.1 millivolt) 
Right Bundle Branch Block 
 Wide QRS, more than 120 ms (3 small squares)  
 An rSR' or rsR' in right-sided lead V1 
 Prominent, delayed and wide terminal S in V5 or V6 
Left Bundle Branch Block 
 Wide QRS, more than 120 ms (3 small squares)  
 An upright (monophasic) QRS complex in leads I and V6 
 A predominantly negative QRS complex in lead V1 
Left anterior hemiblock  
 QRS axis more left than -30 degrees  
 Initial R wave in the inferior leads (II, III and aVF)  
  Absence of any other cause of left axis deviation 
Normal QRS complex 
 < 0.12 s duration (3 small squares) 
 LV Hypertrophy 
 Sokolow’s criterion (S wave in lead V1 [SV1] + R wave in lead V5 
or V6 [RV5 or RV6] > 35 mm) 
RV hypertrophy 
 Dominance of R in right-oriented leads 
 Right axis deviation. 
Using the above criteria each electrocardiogram was read 
and the results were tabulated. These were then analyzed with the data 
obtained from the electrocardiograms of the controls.  
 
 Computation of results 
Of the Electrocardiograms studied in the study group (with 
left ventricular systolic dysfunction) only 2 (4%) were absolutely normal. 
Among the control group 70% of the electrocardiograms were normal.  
 Control Study 
Normal ECG 35 2 
Abnormal 
ECG 
15 48 
 
Age distribution 
The age distribution of the study group was tabulated. The 
youngest person was 24 years old and the oldest patient was 84years old. 
The average age of the study group was 54.7 years. 
 Study Control 
18-29 2 4 
30-39 6 13 
40-49 9 11 
50-59 12 10 
60-69 15 9 
70-79 5 2 
80-89 2 1 
Average  54.7 47.7 
 Sex distribution 
Majority of the patients were male both in the control 
population and in the study population. 
 Study Control 
Male 30 (60%) 30 (60%) 
Female  20 (40%) 20 (40%) 
Total  50 50 
 
Etiology of Heart failure 
In our study majority (68%) of the patients had ischemic 
heart disease. The other causes included hypertensive heart disease, 
valvular heart disease and cardiomyopathies.   
 
Etiology  Study 
Coronary artery disease 32 
Hypertensive heart disease 5 
Valvular heart disease 7 
Cardiomyopathies  6 
 
 Variation in heart rate 
The average resting heart rate in the study group was 99.8 
with a range from 72 to 124. Whereas the average heart rate in the control 
population was 80.16 with a range from 60 to 110. 
 Control Mild Moderate Severe 
Normal rate  
(60 to 100) 
47 15 8 2 
Sinus tachycardia 
(>100) 
3 4 10 4 
Average heart 
rate 
80.16 93.3 103.6 110.5 
 
Rhythm abnormalities 
As the Ejection fraction decreased, then incidence of atrial 
and ventricular ectopics increased. 94% of the control population had 
normal sinus rhythm. This decreased to 42% among those with left 
ventricular systolic dysfunction. 
 Control Mild Moderate Severe 
Normal sinus rhythm 47 15 9 2 
Atrial ectopics 3 3 4 4 
Ventricular ectopics 4 4 5 5 
Atrial fibrillation 0 5 0 2 
 
 Axis deviation 
Normal axis was present in 96% of the control population, 
whereas only 68% of the study population had normal axis. The mean 
axis in control population was 37.5 (range -40 to 70) and in the study was 
20.9 (range -60 to 120). 
 Control Mild Moderate Severe 
Normal Axis 48 17 14 3 
Left axis deviation 2 4 3 5 
Right axis deviation 0 3 1 0 
Extreme axis 0 0 0 0 
Average axis 37.5 36.2 19.16 -21.2 
 
Chamber hypertrophy  
12% of the control population had left ventricular 
hypertrophy. Among the study population 36% had LV hypertrophy and 
4% had RV hypertrophy. 
 
 Control Mild Moderate Severe 
LV hypertrophy 6 11 4 3 
RV hypertrophy 0 2 0 0 
No hypertrophy 44 11 14 5 
 
Conduction Abnormalities  
 Normal conduction was present in 46 (92%) persons of the 
control population. This decreased to 33 (66%) in the study population. 
The most common form of conduction defects was Left Anterior 
Fascicular block. 
 Control Mild Moderate Severe 
Normal 
conduction 
46 20 11 2 
LAFB 2 4 1 3 
RBBB 1 1 2 2 
LBBB 1 1 0 4 
 
Left Atrial Abnormality 
Abnormal wide P waves were present in 48% of the persons 
with left ventricular systolic dysfunction, but occurred only in 10% of 
them with normal left ventricular systolic function. 
 Study Control 
Normal p 26 45 
Abnormal p 
(LA Abnormality) 
24 5 
 QRS Duration 
Average QRS duration in the control population was 86.6 
milliseconds (range 75 to 110). In the group with left ventricular systolic 
dysfunction it was 107.4 milliseconds (range 80 to 140). None of the 
patients in the study population had a QRS duration more than 120 
milliseconds. On the other hand 30% of the study population had QRS 
duration more than 120 milliseconds 
 
QSR 
duration 
Control Mild Moderate Severe 
70-79 1 0 0 0 
80-89 27 6 1 0 
90-99 19 7 3 0 
100-109 2 4 5 0 
110-119 1 4 4 1 
120-129 0 1 4 1 
130-139 0 1 1 2 
140-149 0 1 0 4 
Average 86.6 99.1 107.5 131.85 
 
 Combination of criteria 
Combination 1: Heart rate more than 90, left atrial abnormality and 
 QRS duration >110 milliseconds 
Combination 2: Heart rate more than 90, Axis < 0 or > 90 and QRS 
 duration > 110 milliseconds 
Combination 3: Heart rate more than 90, and QRS duration >110 
 milliseconds 
 Control Study  Mild  Moderate  Severe  
Combination 1 0 11 (22) 5 (20) 3 (16.6) 3(37.5) 
Combination 2 0 12 (24) 2 (8) 4 (22.2) 6 (75) 
Combination 3 0 22 (44) 7 (29) 8 (44.4) 7(87.5) 
 
None of the control population had more than one criteria present. Hence 
none of the combination criteria was present. A combination of Heart rate 
more than 90, and QRS duration >110 milliseconds (combination 3) was 
present in 87.5 % of patients with very low ejection fraction. However all 
3 three combinations were not present in majority of patients with mild 
LV dysfunction. 
 Summary 
Table showing in percentage the difference between the 
heart rate, left atrial abnormality (LAA), ectopics, ventricular 
hypertrophy, and increased QRS duration between the control population 
and the study population. 
 
 Control Study 
Tachycardia 6 34 
L. Atrial Abnorm 10 48 
LAFB 4 16 
Bundle blocks 4 20 
LVH/RVH 12 40 
QSRD > 120 ms 0 30 
 
 Discussion 
 
A total of 100 patients were analyzed in this study of which 
50 were patients with left ventricular systolic dysfunction (EF < 50%) 
and 50 patients with normal left ventricular function. Analysis of the data 
shows us that majority of the patients were male (60%) both in the study 
and control population. 
The most common cause of heart failure in this study was 
coronary artery disease (64%). Similar findings were observed in other 
studies.13 
48 patients in the study population had ECG abnormalities 
(96%). In contrast only 30% had abnormal electrocardiograms among the 
control population. Hence the negative predictive value of a normal 
electrocardiogram is very high.  
Our study showed that as the Ejection fraction decreased the 
resting heart increased. The average heart rate in the control population 
was 80.1 per minute. It increased to 93.3 per minute in the control 
population. In patients with severe left ventricular systolic dysfunction it 
was still higher (110.5 per minute). 34 % of the control population had 
sinus tachycardia and 14% had atrial fibrillation. In strong contrast only 
6% of the control population had sinus tachycardia and none had atrial 
 fibrillation. Hence an increasing heart rate is associated with low EF but 
should be interpreted with the help of associated findings.  
Axis deviation was more in patients with left ventricular 
systolic dysfunction (32% compared to 4% among control population). 
Among this left axis deviation was more common (24%) than right axis 
deviation (12%). However axis deviation cannot be taken as a significant 
ECG criterion as majority of the patients even with left ventricular 
systolic dysfunction (i.e. 68%) had normal axes. 
In our study the QRS duration was the single most important 
ECG criterion strongly associated with left ventricular systolic 
dysfunction. As the QRS duration increased the EF decreased. The 
average QRS duration in the control population was 86.6 milliseconds 
(range 75 to 110). This increased to 107.8 ms in the study population. 
Moreover among patients with severe left ventricular systolic dysfunction 
the average QRS duration was 131.85 milliseconds. Looking at the 
incidence, none of the patients in the study group had QRS duration more 
than 120 milliseconds. This rose to 30 % among the control group. 
Among patients with severe left ventricular systolic dysfunction 87.5% 
had a QRS duration more than 120 milliseconds. 
These results are similar to the conclusions of several studies 
which have proved that intraventricular conduction delay is associated 
 with more advanced myocardial disease including those by A P Davie, 
Amir Kashani, Das MK, Cheripambil K, Bedi A, et al.33, 34, 35 
Left atrial abnormality as evidenced by abnormal P waves is 
another ECG criterion closely associated with left ventricular systolic 
dysfunction. In our study 48 % of the patients with left ventricular 
systolic dysfunction had left atrial abnormality, while it was present in 
only 10% of the control population. Thus in the absence of systemic 
hypertension and mitral valve disease, left atrial abnormality can be taken 
as an indicator to the presence of left ventricular dysfunction. 
34% of our patients in study population had conduction 
abnormalities, compared to only 8 % of the control population. The most 
common abnormality was Left anterior fascicular block. However, in 
patients with severe left ventricular systolic dysfunction 50 % had a left 
bundle branch block. Studies done by Das MK, Cheripambil K, Bedi A, 
et al and Murkofsky RL et al also confirms similar observation that 
LBBB is a marker of significant left ventricular systolic dysfunction.35, 36  
12% of the control population had left ventricular 
hypertrophy. Among the study population 36% had LV hypertrophy and 
4% had RV hypertrophy. Although incidence of LV hypertrophy is more 
in the study population, chamber hypertrophy is both non specific and 
non sensitive in detecting left ventricular systolic dysfunction.  
 Finally in this study combination of several ECG criteria 
were used. A combination of heart rate more than 90, left atrial 
abnormality and QRS duration >110 milliseconds was present in 37.5% 
of patients with severe LV dysfunction but in only 20% of the mild LV 
dysfunction group. Another combination of Heart rate more than 90, and 
QRS duration >110 milliseconds was present in majority (87.5%) of 
patients with severe LV dysfunction but in only 29% of the mild LV 
dysfunction group.  However none of the control population had more 
than single ECG abnormality. Hence use of combination criteria would 
only detect patients with severe LV dysfunction. 
 
 
 
    
 
 
 Limitations of our study 
1. The etiology of heart failure in most of the patients in the study 
population was coronary artery disease. The electrocardiographic 
changes produced by ischemia in those patients could be a source 
of error. 
2. In view of the high incidence of coronary artery disease, certain 
criteria such as Q waves, ST segment and T wave changes were not 
used for analysis. 
3. This study had certain confounding factors such as age, 
emphysema, obesity, electrolyte imbalance, drugs etc. which could 
alter the surface electrocardiogram. 
4. The study population is small and the design was retrospective. A 
larger study population and a prospective study may have produced 
different results. 
 Conclusions 
1. Coronary artery disease is the most common cause of left 
ventricular systolic dysfunction. 
2. There is a consistent association between the standard 12 lead 
electrocardiogram and left ventricular systolic dysfunction. 
3. A normal electrocardiogram virtually excludes chronic heart 
failure due to left ventricular systolic dysfunction.  
4. There are usually major electrocardiographic abnormalities as the 
severity of left ventricular systolic dysfunction increases. 
5. The resting heart rate increases consistently with decreasing left 
ventricular systolic function. 
6. Ectopic activity (Both Atrial and ventricular) increases with 
decreasing left ventricular ejection fraction. 
7. Conduction defects increases with worsening Left ventricular 
systolic function. Left anterior fascicular block is the most 
common conduction abnormality. However a Left bundle branch 
block is more common in those with severe left ventricular systolic 
dysfunction. 
8. Increasing QRS duration is the single most specific criteria which 
correlates well with decreasing ejection fraction. A QRSD duration 
more than 120 milliseconds especially in the absence of a typical 
 conduction defect signifies significant left ventricular systolic 
dysfunction 
9. Among the electrocardiographic abnormalities a combination of 
sinus tachycardia, left Atrial abnormalities and QRS duration were 
found to be most specific but loses sensitivity. 
10. The electrocardiogram is not a substitute for echocardiography, as 
an abnormal electrocardiogram does not accurately predict the 
presence of left ventricular systolic dysfunction. 
11. An abnormal electrocardiogram does not mean that the patient has 
chronic heart failure but is an indication for an echocardiogram. 
S.N
o. 
Name  A 
G 
E 
S
e
x 
Cause  EF Rate Rhythm Axis LAA LAFB QRSD APC VPC LVH RVH RBBB LBBB 
1 Raghu 35 M CM 25 120 ST -40 +
 
+ 140 -- -- -- -- + -- 
2 Vaidyanathan 50 M CAD 35 124 ST -45 + -- 85 + -- -- -- -- --  
3 Revathi 56 F CAD 40 78 NSR 30 -- -- 110 -- -- + -- -- -- 
4 Muhtulaxmi 84 F CAD 42 120 AF 25 NA -- 120 NA + -- -- -- -- 
5 Varadhan 65 M Valv 44 98 NSR 40 + -- 110 -- -- -- -- -- -- 
6 Destagiri 58 M CAD 40 102 ST -50 + + 130 + + -- -- -- + 
7 Padma 40 F CAD 48 90 NSR 30 -- -- 110 -- -- + -- -- -- 
8 Devika 25 M Valv 40 75 AF 120 + -- 90 + -- + -- -- -- 
9 Jeyaraman 80 M CAD 45 110 ST 50 --  -- 80 -- -- -- -- -- -- 
10 Mary 32 F CM 35 98 NSR -35 + + 125 -- -- -- -- + -- 
11 Yunus 63 M CAD 28 72 NSR -60 + + 110 + + + -- -- -- 
12 Thulukanam 52 M Valv 39 110 ST 45 + -- 100 -- -- + -- -- -- 
13 AbdulMazzed 75 M CM 30 98 NSR 60 -- -- 120 -- + -- -- --  -- 
14 Ulaganathan 51 M CM 25 100 NSR 20 -- -- 140 -- -- -- -- -- -- 
15 Ahamed 65 M CAD 32 110 ST  35 -- -- 95 -- + + -- -- -- 
16 Annaraj 46 M CAD 42 75 NSR 35 + -- 85 -- -- -- -- -- -- 
17 Samuel 24 M Valv 49 100 AF 110 NA -- 90 NA + + + -- -- 
18 Aarthi 42 F CAD 38 98 NSR 60 -- -- 90 -- -- -- -- -- -- 
19 Devika 70 F CAD 42 110 ST 55 + -- 95 -- -- -- -- -- -- 
20 James 40 M HHD 49 86 AF 30 NA -- 100 -- -- + -- -- -- 
21 Allah Basha  58 M CAD 30 120 ST -35 -- -- 125 + -- -- -- + -- 
22 Parvathi 60 F CAD 28 122 ST -45 + -- 130 + -- + -- -- + 
23 Laxmi 62 F CAD 39 98 NSR 100 + -- 105 -- -- + -- -- -- 
24 Mohammed 55 M HHD 45 74 NSR 30 + -- 85 -- -- + -- -- -- 
25 Prabu  65 M CM 26 112 AF -35 NA + 140 + + -- -- + -- 
Master Chart – study population - I 
S.N
o. 
Name  Ag
e 
S
e
x 
Cause  EF Rate Rhythm Axis LAA LAFB QRSD APC VPC LVH RVH RBBB LBBB 
26 Prasanna 48 M CAD 45 86 NSR 50 -- -- 85 -- -- -- -- -- -- 
27 Anandhi 54 F CAD  38 86 NSR 40 -- -- 100 -- + -- -- -- -- 
28 Kavya 66 F CAD 32 110 ST 30 + -- 110 + -- -- -- -- -- 
29 Rajan 47 M Valv 45 100 NSR 30 + -- 110 -- -- + -- -- -- 
30 Vijay Anand 68 M CAD 25 120 ST -50 -- -- 140 -- + -- -- -- + 
31 Meghala 58 F CAD 40 82 NSR 55 -- -- 85 + -- -- -- -- -- 
32 Hameedha 53 F CAD 39 86 NSR 40 + -- 95 -- -- + -- -- -- 
33 Hareesh 60 M CAD 45 92 NSR 50 -- -- 80 -- + -- -- -- -- 
34 Vijay Kanna 58 M CAD 30 112 ST 10 -- -- 120 -- + -- -- -- -- 
35 Armugam 31 M HHD 49 92 NSR -50 + + 90 -- -- + -- -- -- 
36 Barathan 65 M CAD 31 98 NSR 15 -- -- 110 -- + -- -- -- -- 
37 Vasanthi 75 F CAD 49 100 NSR 50 -- -- 100 -- -- + -- -- -- 
38 Sundeep 72 M CAD 34 112 ST -20 -- -- 105 -- -- -- -- -- -- 
39 Rohini 39 F Valv 45 96 AF 120 NA -- 95 + -- -- + -- -- 
40 Karpagam 48 F HHD 41 98 NSR -40 + + 90 --  + + -- -- -- 
41 Kannan 62 M CAD 32 112 ST 00 -- -- 115 -- +  -- -- -- -- 
42 Satheesh 64 M CAD 47 98 ST 10 + -- 90 -- -- + -- -- -- 
43 Vidya 48 F CAD 21 120 AF 60 NA -- 130 NA + -- -- -- + 
44 Hariprasad 52 M CAD 42 86 NSR 55 -- -- 110 -- -- -- -- -- -- 
45 Shakunthala 68 F CAD 39 110 ST 35 + -- 115 -- -- -- -- -- -- 
46 Guruprasath 35 M CM 25 118 ST -20 + -- 125 + + + -- -- + 
47 Prakash 72 M CAD 49 94 NSR 70 + -- 100 -- -- -- -- -- -- 
48 Ravindar 42 M HHD 40 98 NSR -35 + + 140 -- -- + + + -- 
49 Kalpana 32 F Valv 38 112 ST 00 + -- 100 -- -- -- -- -- -- 
50 Geetha  65 F CAD 35 82 NSR 10 -- -- 120 + -- -- -- -- -- 
Master Chart – study population - II 
S.N
o. 
Name  A 
G 
E 
S
e
x 
EF Rate Rhythm Axis LAA LAF
B 
QRSD APC VPC LVH RVH RBBB LBBB 
1 Prasanna 48 M 55 72 NSR 25 -- -- 85 -- -- -- -- -- -- 
2 Radha 54 F 65 68 NSR 35 -- -- 85 -- -- -- -- -- -- 
3 Kiran joseph 66 M 50 88 NSR 40 -- -- 90 -- -- -- -- -- -- 
4 Shyam 47 M 60 62 NSR -10 -- -- 80 -- + -- -- -- -- 
5 Prathap 68 M 65 85 NSR 55 -- -- 90 -- -- -- -- -- -- 
6 Vidya 58 F 70 74 NSR 10 + -- 80 -- -- + -- -- -- 
7 Hareesh 53 M 65 70 NSR 50 -- -- 90 -- -- -- -- -- -- 
8 Sunil 40 M 52 84 NSR 60 -- -- 100 -- -- -- -- -- -- 
9 Preethi 58 F 54 72 NSR 65 -- -- 90 -- -- -- -- -- -- 
10 Laxmi 31 F 68 74 NSR 70 -- -- 85 -- -- -- -- -- -- 
11 Arun rathnam 65 M 63 85 NSR 65 -- -- 85 + -- -- -- -- -- 
12 Shanthakumar 35 M 70 69 NSR 00 -- -- 80 -- -- -- -- -- -- 
13 Joel 50 M 58 93 NSR 54 -- -- 75 -- -- -- -- -- -- 
14 Anuradha 56 F 56 73 NSR 40 -- -- 80 -- -- -- -- -- -- 
15 Gnanam 70 M 50 80 NSR 10 -- -- 85 -- -- -- -- -- -- 
16 Anjana 65 F 63 85 NSR 70 -- -- 90 -- -- -- -- -- -- 
17 Bennett 58 M 67 70 NSR 15 -- -- 90 -- + -- -- -- -- 
18 Ponammal 40 F 62 94 NSR 56 -- -- 85 -- -- -- -- -- -- 
19 Sandhya 25 F 68 98 NSR 50 -- -- 85 -- -- -- -- -- -- 
20 Ahmed  80 M 60 104 ST -35 + + 100 -- -- + -- -- -- 
21 Kalyan  32 M 55 74 NSR 35 -- -- 90 -- -- -- -- -- -- 
22 Nimbi 63 M 55 79 NSR 40 -- -- 80 -- -- -- -- -- -- 
23 Preethi 52 F 54 73 NSR 42 + -- 90 -- -- + -- -- -- 
24 Sangeetha 45 F 60 72 NSR 40 -- -- 80 -- -- -- -- -- -- 
25 Narayanan  35 M 68 60 NSR 40 -- -- 90 + -- -- -- -- -- 
Master Chart – control population - I 
S.N
o. 
Name  Ag
e 
S
e
x 
EF Rate Rhythm Axis LAA LAF
B 
QRSD APC VPC LVH RVH RBBB LBBB 
26 Fernandez  42 M 52 86 NSR -10 -- -- 85 -- -- -- -- -- -- 
27 Gayathri  39 F 57 86 NSR 64 -- -- 90 -- -- -- -- -- -- 
28 Yunus khan 48 M 68 90 NSR 65 -- -- 90 + -- -- -- -- -- 
29 Prem kumar 62 M 72 79 NSR 62 -- -- 85 -- -- -- -- -- -- 
30 Robert  64 M 64 60 NSR -40 -- + 110 -- -- + -- -- + 
31 Seethalaxmi 48 F 65 82 NSR 52 -- -- 90 -- -- -- -- -- -- 
32 Bharath 52 M 62 86 NSR 58 -- -- 80 -- -- -- -- -- -- 
33 Amrutha 68 F 58 92 NSR 50 -- -- 90 -- -- -- -- -- -- 
34 Ravikumar 35 M 52 68 NSR 60 -- -- 80 -- + -- -- -- -- 
35 Dinesh 32 M 58 73 NSR 30 + -- 90 -- -- + -- -- -- 
36 Hameedha 42 F 50 90 NSR 63 -- -- 85 -- -- -- -- -- -- 
37 Kandan 32 M 60 73 NSR 20 -- -- 85 -- -- -- -- -- -- 
38 Menon  65 M 66 79 NSR 65 -- -- 90 -- -- -- -- -- -- 
39 Keerthi 52 M 63 65 NSR 10 -- -- 85 -- -- -- -- -- -- 
40 Tarakeshwari 39 F 70 65 NSR 68 -- -- 90 -- -- -- -- -- -- 
41 Ajay  28 M 65 78 NSR 25 -- -- 90 -- -- -- -- -- -- 
42 Srividya 34 F 54 90 NSR 35 -- -- 85 -- -- -- -- -- -- 
43 Deepa 70 F 68 110 ST 40 -- -- 80 -- + -- -- -- -- 
44 Lawerance  31 M 52 86 NSR 42 -- -- 80 -- -- -- -- -- -- 
45 Chandran  45 M 58 100 ST 15 -- -- 85 -- -- -- -- -- -- 
46 Shakunthala 28 F 70 70 NSR 40 -- -- 85 -- -- -- -- -- -- 
47 Nandhini 30 F 53 94 NSR 20 + -- 90 -- -- + -- -- -- 
48 Radhika  41 F 50 98 NSR 40 -- -- 80 -- -- -- -- + -- 
49 Guru Prasad 29 M 60 68 NSR 45 -- -- 90 -- -- -- -- -- -- 
50 Jeyakumar  35 M 65 82 NSR 35 -- -- 80 -- -- -- -- -- -- 
Master Chart – control  population - II 
Bar diagram showing number of normal and  
abnormal ECGs between the populations 
 
 
 
 
 
 
 
 
 
Bar diagram showing Age distribution 
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Bar diagram showing etiology of  
LV dysfunction among the Study population 
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Bar diagram showing normal rates and tachycardia  
among the Study and control populations in percentage  
 
 
 
 
 
 
 
 
 
Bar diagram showing various rhythms (percentage) 
among the Study and control populations 
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Bar diagram showing normal and abnormal axis 
among the Study and control populations in percentage 
 
 
 
 
 
 
 
 
 
Bar diagram showing ventricular hypertrophy 
among the Study and control populations in percentage 
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Bar diagram showing conduction defects (percentage) 
among the Study and control populations 
 
 
 
 
 
 
 
 
 
Bar diagram showing Left atrial abnormality (Abnormal P) 
among the Study and control populations 
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Bar diagram showing QRS duration in milliseconds  
among the Study and control populations 
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Bar diagram showing various combination of ECG criteria 
among the Study and control populations 
 
 
 
 
 
 
 
 
Bar diagram showing various ECG criteria (in %) 
among the Study and control populations 
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A diagram showing basic ECG waves and intervals 
  
 
 
 
 
An illustration depicting right and left bundle branch blocks 
  
 
 
 
 
 
 
 
 
 
Apical four-chamber view of a patient with a dilated 
cardiomyopathy as visualize by Echocardiography.   
  
 
 
 
 
 
 
 
 
This ECG shows left anterior fascicular block 
This ECG shows left bundle branch block 
  
 
 
 
 
 
 
 
This ECG shows left ventricular hypertrophy, 
left atrial abnormality and a ventricular ectopic 
This ECG shows right bundle branch block 
  
 
 
 
 
This ECG shows right axis deviation and right 
ventricular hypertrophy 
Study Performa 
Name 
Age 
Sex 
O.P. No. 
Current NYHA Class 
Ejection Fraction 
Etiology of Heart Failure 
Rate 
 Normal 
 Bradycardia 
 Tachycardia 
Rhythm 
 Normal Sinus 
 Atrial Ectopics 
 Ventricular Ectopics 
 Atrial Arrhythmias 
  Ventricular Arrhythmias 
Axis 
 Normal 
 Left Axis Deviation 
 Right Axis Deviation 
P Wave Morphology 
 Normal 
 Left Atrial Abnormality 
QRS duration 
 <120 ms 
 >120 ms 
Conduction Defects 
 None 
 Right Bundle Branch Block 
 Left Bundle Branch Block 
 Left Anterior Fascicular Block 
 Others  
Left Ventricular Hypertrophy 
 Present  
 Absent 
Right Ventricular Hypertrophy 
 Present  
  Absent 
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